TLDR Baricitinib might help treat hair loss in lupus patients, but more research is needed.
The study investigated the efficacy of Baricitinib, a JAK 1/2 inhibitor, in treating diffuse non-scarring alopecia in patients with systemic lupus erythematosus (SLE). The JAK-STAT pathway, crucial for type I interferons, is implicated in SLE-associated inflammation. Baricitinib, already approved for rheumatoid arthritis, showed promise in improving SLE symptoms like arthritis and rash, though specific effects on skin involvement, including alopecia, were not detailed. Diffuse non-scarring alopecia, a common but non-life-threatening symptom of SLE, significantly impacts patients' quality of life.
19 citations
,
August 2019 in “Dermatologic therapy” Janus kinase inhibitors show promise for treating alopecia areata but need more research for confirmation.
32 citations
,
December 2018 in “Cytokine” Type I interferons play a key role in the development of various skin diseases.
46 citations
,
June 2018 in “American Journal of Clinical Dermatology” Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.
701 citations
,
August 2014 in “Nature medicine” Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.
15 citations
,
December 2011 in “Journal of the European Academy of Dermatology and Venereology” Hair loss in systemic lupus erythematosus patients is unique and improves with treatment.
6 citations
,
April 2021 in “Frontiers in Immunology” A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.
1 citations
,
March 2023 in “Clinical, Cosmetic and Investigational Dermatology” Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.
November 2023 in “Research Portal Denmark” Baricitinib shows promise for severe alopecia areata but isn't a cure and has side effects.
March 2022 in “Wound practice & research” New treatments for alopecia areata show promise, but standardized guidelines are needed.
February 2021 in “Journal of pharmaceutical and biological sciences” No cure exists for alopecia areata, and treatments are personalized.